Kestra Medical Technologies (KMTS) Earnings Date
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
Estimate-vs-actual scoring began Jul 2026. Earlier quarters predate our snapshots, so their surprise stays "—". We never backfill an estimate we didn't observe.
| Report | Est EPS | Act EPS | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|
| Sep 14, 20268-K, after close · 4:01 pm ET | −0.62 | −0.75 | $29.0M | $31.0M | +6.8% | +4.7%next session |
| Mar 17, 20268-K, after close · 4:04 pm ET | — | −0.61 | — | $24.6M | — | −7.4%next session |
| Dec 11, 20258-K, after close · 4:03 pm ET | — | −0.64 | — | $22.6M | — | +5.1%next session |
| Sep 11, 20258-K, after close · 4:17 pm ET | — | −0.50 | — | $19.4M | — | +18.6%next session |
| Jul 15, 20258-K, after close · 4:12 pm ET | — | −2.74 | — | $2.8M | — | −5.8%next session |
| Apr 14, 20258-K, after close · 4:13 pm ET | — | −1.25 | — | $15.1M | — | +1.3%next session |
| Dec 5, 2024 E | — | −1.19 | — | $14.7M | — | —estimated date |
| Sep 4, 2024 E | — | −1.12 | — | $12.8M | — | —estimated date |
E marks a report date we estimated from the fiscal period end, because we found no results release and no usable filing date for that quarter. Those rows show no reaction: a move measured from a day we guessed is not a reaction to the release, and we would rather leave it blank than publish it.
| Measure | Oct '26 | Jan '27 | FY27 | FY28 |
|---|---|---|---|---|
| No. of analysts | 3 | 3 | 5 | 5 |
| Avg estimate | −0.61 | −0.58 | −2.45 | −2.05 |
| Low estimate | −0.62 | −0.59 | −2.48 | −2.29 |
| High estimate | −0.59 | −0.57 | −2.42 | −1.92 |
| Year-ago EPS | −0.64 | −0.61 | −2.43 | −2.45E |
| Implied growth | — | — | — | — |
| Measure | Oct '26 | Jan '27 | FY27 | FY28 |
|---|---|---|---|---|
| No. of analysts | 6 | 6 | 7 | 7 |
| Avg estimate | $32.1M | $35.5M | $140.9M | $196.0M |
| Low estimate | $32.0M | $35.4M | $140.7M | $191.0M |
| High estimate | $32.2M | $35.5M | $140.9M | $201.3M |
| Year-ago revenue | $22.6M | $24.6M | $95.1M | $140.9ME |
| Implied growth | +42.2% | +44.5% | +48.1% | +39.2% |
| Snapshot age | Oct '26, period ending Oct 31, 2026 | Jan '27, period ending Jan 31, 2027 | FY27, period ending Apr 30, 2027 | FY28, period ending Apr 30, 2028 |
|---|---|---|---|---|
| Current estimate | −0.61 | −0.58 | −2.45 | −2.05 |
| 7 days ago | −0.61 | −0.58 | −2.45 | −2.05 |
| 30 days ago | −0.61 | −0.58 | −2.45 | −2.11 |
| 60 days ago | −0.61 | −0.58 | −2.45 | −2.11 |
| 90 days ago | −0.60 | — | −2.30 | −2.07 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Oct '26 quarter consensus moved $−0.60 → $−0.61 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
What were Kestra Medical Technologies' latest quarterly earnings?
Kestra Medical Technologies reported diluted EPS of −0.75 and revenue of $31.0M on Sep 14, 2026.
How did Kestra Medical Technologies' stock move after its last earnings report?
Kestra Medical Technologies moved +4.7% in the session after its Sep 14, 2026 report.

